Xylazine wounds are deep, slow-healing skin and soft-tissue ulcers linked to xylazine, a veterinary sedative now common in the illicit fentanyl supply. A mobile program can prevent sepsis, necrosis, and amputation from these wounds by delivering low-barrier wound assessment, cleaning, and dressing on a predictable schedule; supplying wound care kits; treating or referring infections early; and pairing every wound visit with overdose response and a warm connection to treatment. The wounds appear on people who use drugs regardless of injection site, and they worsen fast without care, so the goal is to reach people where they already are and to keep showing up.
The urgency is documented. In April 2023, the federal government designated fentanyl adulterated or associated with xylazine an "emerging threat". Mobile wound care meets a need that fixed sites often miss, and it works best when it runs through a behavioral health satellite clinic network built for continuity.
Xylazine is a veterinary sedative that has entered the illicit drug supply, most often mixed with fentanyl. It is not approved for use in people. Sellers add it because it extends and deepens the sedative effect of fentanyl, which changes how the drug feels and how long it lasts.
The spread is measurable. In 2022, the DEA found that about 23% of seized fentanyl powder and about 7% of fentanyl pills contained xylazine. Because xylazine now travels with fentanyl across much of the supply, any program serving people who use opioids is likely serving people exposed to xylazine, whether or not they know it. That reality shapes how a mobile team plans wound care, overdose response, and testing. Program leaders building this capacity can align it with a broader primary care satellite clinic network so wound patients have somewhere to go for follow-up.
Xylazine causes wounds because of how it acts on blood vessels. It is an alpha-2 adrenergic agonist, and its peripheral vasoconstriction contributes to deep ulcerative wounds and poor healing. When small vessels tighten, tissue gets less blood and oxygen, so skin breaks down and struggles to repair.
These wounds differ from typical injection-site abscesses in two ways that matter for care. They can appear on parts of the body away from injection sites, and they tend to grow and deepen rather than resolve on their own. A team that understands the mechanism will assess the whole body, not only the arms, and will plan for repeat visits because a single dressing change rarely finishes the job. Consistent staffing supports that kind of longitudinal care, which is why we recommend dedicated mobile-program staff over any rotating arrangement. MMM's planning and staffing advisory helps programs design that model.
The risk is serious and it compounds over time. Severe xylazine cases cause soft-tissue necrosis and can lead to amputation. Necrotic tissue and open wounds create a path for infection, and untreated infection can progress to sepsis, a life-threatening response that spreads through the body.
Several conditions raise the stakes for people who use drugs. Wound infection is common due to poor living conditions, limited health-care access, and inadequate hygiene. A person who cannot easily wash, store dressings, or reach a clinic will see a small wound become a large one. Early, repeated wound care interrupts that path. The clinical signs a mobile team watches for include:
Any of these signs calls for escalation to emergency care, and a mobile program should build those referral relationships before it needs them.
Naloxone alone is not enough because xylazine and fentanyl are different kinds of drugs. Xylazine is not an opioid, so naloxone does not reverse its sedative effects. Naloxone still reverses the fentanyl, which is the part that stops breathing, so teams and community members should always give naloxone in a suspected opioid overdose.
The practical guidance follows from the biology. Give naloxone to address the fentanyl and the respiratory depression it causes. Then expect that the person may stay sedated from the xylazine even after the opioid is reversed, so keep monitoring breathing, position the person to protect the airway, and call for emergency help. Training frontline staff and outreach workers to respond this way is part of a working overdose response plan, and it belongs in every mobile program serving areas where fentanyl and xylazine circulate together.
A mobile program delivers wound care by bringing assessment, cleaning, dressing, supplies, and follow-up to the places people already gather, on a schedule they can count on. The model works because it removes the travel, wait, and stigma that keep people from fixed clinics, and because it returns often enough to catch problems early.
Staff the wound care program with people hired for the mobile program. Dedicated staff build trust with a community that has often been turned away, and they keep the schedule reliable. Rotating fixed-site clinicians onto the unit breaks that continuity and makes the mobile program the first thing cut when a fixed site loses a clinician. Programs can build role clarity and skills through structured planning and staffing support.
Wound care connects people to treatment because it is a reason to come, a reason to return, and a moment of trust. Someone who will not walk into a clinic for opioid use disorder will often accept help for a painful wound, and each visit is a chance to offer testing, medications for opioid use disorder, and other services without pressure.
The connection depends on continuity. When the same trusted team sees a person across several visits, offers of treatment land differently than a one-time referral does. That is another reason to run wound care through a stable behavioral health satellite clinic network staffed by people who stay. Wound care opens the door; the relationship is what carries someone through it.
Naloxone does not reverse xylazine, because xylazine is not an opioid. It does reverse the fentanyl that is usually present, which is the drug that suppresses breathing, so responders should always give naloxone in a suspected opioid overdose. Because the person may stay sedated from xylazine after the opioid is reversed, keep monitoring breathing and call for emergency help.
It is widespread in the fentanyl supply. In 2022, the DEA found that about 23% of seized fentanyl powder and about 7% of fentanyl pills contained xylazine. The federal government named fentanyl associated with xylazine an emerging threat in April 2023.
Yes. Severe xylazine cases cause soft-tissue necrosis and can lead to amputation. Early and repeated wound care lowers that risk by treating small wounds before they deepen and by catching infection before it spreads.
Mobile wound care reaches people who face travel, wait times, and stigma at fixed clinics, and it returns often enough to catch problems early. Wound infection is common among people who use drugs due to poor living conditions, limited health-care access, and inadequate hygiene, so bringing care to them changes outcomes. It also creates repeated, trusted contact that can open the door to treatment.
Staff the program with people hired for the mobile unit. Dedicated staff keep the schedule reliable and build trust in communities that have often been turned away.
If your team is planning wound care for people who use drugs and wants a model built for continuity and trust, MMM can help you design and staff it. Start with our behavioral health satellite clinic network to see how mobile programs deliver low-barrier care that connects people to treatment.